IMM 11.9% 29.5¢ immutep limited

Biotech Roundtable - virtual event in Germany

  1. 30 Posts.
    lightbulb Created with Sketch. 18
    A great opportunity to hear Marc speak......

    DGWA and the German Australian Business Council are delighted to host the following virtual event. CEO Roundtable: Biotech Breakthroughs across Australia and Germany Tuesday, 1 March 2022 8:00am – 9:00 CET Online

    The global spotlight on the biotech industry over the pandemic has highlighted the importance and impact of the industry while accelerating innovation and investment across countries and companies. Join this discussion with leading CEOs from Australia and Germany as they navigate the biotech landscape from clinical trials to engaging stakeholders on their paths to commercial success.The speakers are:James Graham – CEO, Recce Pharmaceuticals, Mark Diamond – Managing Director & CEO, Antisense Therapeutics, Dr. Mohit Chhaya – Co-Founder & CEO, BellaSeno, Marc Voigt – CEO & Executive Director, Immutep

    The session will be moderated byr. Julia Schueler - Chair, Founder & Owner Bio.AspekteDr. Lucia Santoso – Incoming Board Member, German Australian Business CouncilRegistrations:

    https://us02web.zoom.us/meeting/register/tZUucu2uqzgrGNxWPzMcnXaQ_kBF-WHacj58
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.040(11.9%)
Mkt cap ! $428.5M
Open High Low Value Volume
32.0¢ 33.0¢ 28.0¢ $7.278M 23.75M

Buyers (Bids)

No. Vol. Price($)
4 53192 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 41048 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.